Streetbeat News

Stock Prices

TWFG

Trading halt status was updated at 10:10:00 AM ET for an IPO security, which has now been released for quotation.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 2:10 pm

DFS

Discover Financial Services shares are trading higher after the company reported better-than-expected Q2 EPS results.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 2:09 pm

SPY

Federal Reserve's Goolsbee stated that recent inflation data has been positive, but the fight against inflation is not over. He also noted that the labor market is cooling, leading to a better balance.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 2:07 pm

BX

Blackstone shares are trading higher following Q2 earnings.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 2:06 pm

AGEN

CHUY

DHI

FTEL

LESL

ONCO

SILO

US stocks edged higher with the Dow Jones, NASDAQ, and S&P 500 all posting gains. D.R. Horton reported better-than-expected earnings, while Onconetix, Silo Pharma, and Chuy’s Holdings saw significant stock price increases. Agenus, Leslie’s, and Fitell Corporation experienced notable declines.

Portfolio Pulse from Avi Kapoor

July 18, 2024 | 2:04 pm

AMD

BYND

DPZ

LESL

NVDA

Bitcoin Spot ETFs continue to see inflows, while Trump's comments on Taiwan and Biden's trade plans trigger a selloff in semiconductor stocks. Leslie's, Beyond Meat, and Domino's are among the big stocks moving lower in pre-market trading. Nvidia and AMD are particularly affected by the semiconductor selloff.

Portfolio Pulse from Akanksha Bakshi

July 18, 2024 | 2:04 pm

USB

Analysts have provided mixed ratings for U.S. Bancorp (NYSE:USB) over the past quarter, with a range of price targets and opinions. The average 12-month price target is $45.43, with a high of $49.00 and a low of $42.00. Recent financials show challenges in revenue growth, net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

July 18, 2024 | 2:02 pm

WOOF

Analysts have provided mixed ratings for Petco Health and Wellness (NASDAQ:WOOF) over the past three months, with a recent average price target of $3.71. The company's financial metrics, including revenue growth, net margin, ROE, ROA, and debt-to-equity ratio, indicate challenges in achieving strong financial performance.

Portfolio Pulse from Benzinga Insights

July 18, 2024 | 2:01 pm

PRGS

In the last three months, 5 analysts have provided ratings for Progress Software (NASDAQ:PRGS), ranging from bullish to indifferent. The average 12-month price target is $63.6, with a high of $68.00 and a low of $55.00. Recent ratings include one raise, three maintains, and one lower. Financial metrics show challenges in revenue growth, ROE, and ROA, but strong net margins.

Portfolio Pulse from Benzinga Insights

July 18, 2024 | 2:01 pm

FDMT

Analysts have provided mixed ratings for 4D Molecular Therapeutics (NASDAQ: FDMT) over the past three months, with a recent trend towards somewhat bullish sentiments. The average 12-month price target has decreased from $42.60 to $38.0. Key analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Despite a significant decline in revenue growth and negative net margins, the company shows strong ROE and ROA, and maintains a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

July 18, 2024 | 2:00 pm